Tokyo, Sept. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062601) titled 'Stimulation conditions for transcranial magnetic stimulation producing somatosensory extinction phenomena.' on Sept. 1.
Study Type:
Interventional
Study Design:
Basic Design - Factorial
Randomization - Randomized
Blinding - Single blind -participants are blinded
Control - Active
Primary Sponsor:
Institute - International University of Health and Welfare
Condition:
Condition - Healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Investigation of neural substitutes underlying sensory extinction caused by transcranial magnetic stimulation
Basic objectives2 - Bio-availability
Intervention:
Interventions/Control_1 - TMS coil orientation (PA vs AP)
Interventions/Control_2 - Single pulse vs dual pulse
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - Healthy adults who give informed consent by document after fully explained about the experiments
Key exclusion criteria - [1] No ongoing treatment or history of neurological or psychiatric disorders (e.g. excluding febrile convulsions).
[2] Pregnant or possibly pregnant women.
[3] With motor system disorders in both upper limbs (e.g. fractures, burns).
[4] Persons with metallic objects that interfere with transcranial magnetic stimulation, i.e. those with MRI-qualified pacemakers or magnetic substances in the body.
[5] Persons with metabolic disorders due to internal diseases such as cancer or chronic hepatitis, the effects of which on brain function cannot be ruled out.
Target Size - 15
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 01 Month 01 Day
Anticipated trial start date - 2025 Year 02 Month 01 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063984
Disclaimer: Curated by HT Syndication.
